Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9).

Aparicio T, Ghiringhelli F, Boige V, Le Malicot K, Taieb J, Bouché O, Phelip JM, François E, Borel C, Faroux R, Dahan L, Jacquot S, Genet D, Khemissa F, Suc E, Desseigne F, Texereau P, Lepage C, Bennouna J; PRODIGE 9 Investigators.

J Clin Oncol. 2018 Mar 1;36(7):674-681. doi: 10.1200/JCO.2017.75.2931. Epub 2018 Jan 18.

PMID:
29346040
2.

Autologous Myoblasts for the Treatment of Fecal Incontinence: Results of a Phase 2 Randomized Placebo-controlled Study (MIAS).

Boyer O, Bridoux V, Giverne C, Bisson A, Koning E, Leroi AM, Chambon P, Déhayes J, Le Corre S, Jacquot S, Bastit D, Martinet J, Houivet E, Tuech JJ, Benichou J, Michot F; and the Study Group of Myoblast Therapy for Faecal Incontinence.

Ann Surg. 2018 Mar;267(3):443-450. doi: 10.1097/SLA.0000000000002268.

3.

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.

Besse B, Mazières J, Ribassin-Majed L, Barlesi F, Bennouna J, Gervais R, Moreau L, Berard H, Debieuvre D, Molinier O, Moro-Sibilot D, Souquet PJ, Jacquot S, Petit L, Lena H, Pignon JP, Lacas B, Morin F, Milleron B, Zalcman G, Soria JC; Intergroupe Francophone de Cancérologie Thoracique (IFCT).

Ann Oncol. 2017 May 1;28(5):1078-1083. doi: 10.1093/annonc/mdx070.

PMID:
28327934
4.

Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations.

Wang Y, Ma CS, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, Payne K, Crestani E, Roncagalli R, Belkadi A, Kerner G, Lorenzo L, Deswarte C, Chrabieh M, Patin E, Vincent QB, Müller-Fleckenstein I, Fleckenstein B, Ailal F, Quintana-Murci L, Fraitag S, Alyanakian MA, Leruez-Ville M, Picard C, Puel A, Bustamante J, Boisson-Dupuis S, Malissen M, Malissen B, Abel L, Hovnanian A, Notarangelo LD, Jouanguy E, Tangye SG, Béziat V, Casanova JL.

J Exp Med. 2016 Oct 17;213(11):2413-2435. Epub 2016 Sep 19.

5.

The impact of raw materials and baking conditions on Maillard reaction products, thiamine, folate, phytic acid and minerals in white bread.

Helou C, Gadonna-Widehem P, Robert N, Branlard G, Thebault J, Librere S, Jacquot S, Mardon J, Piquet-Pissaloux A, Chapron S, Chatillon A, Niquet-Léridon C, Tessier FJ.

Food Funct. 2016 Jun 15;7(6):2498-507. doi: 10.1039/c5fo01341k.

PMID:
26974195
6.

Maintaining professional activity during breast cancer treatment.

Ganem G, Antoine EC, Touboul C, Naman H, Dohollou N, Facchini T, Coscas Y, Lortholary A, Catala S, Jacquot S, Lhomel C, Eisinger F.

Eur J Cancer Care (Engl). 2016 May;25(3):458-65. doi: 10.1111/ecc.12460. Epub 2016 Feb 18.

PMID:
26891443
7.

Potential of fluorescence spectroscopy to predict fatty acid composition of beef.

Aït-Kaddour A, Thomas A, Mardon J, Jacquot S, Ferlay A, Gruffat D.

Meat Sci. 2016 Mar;113:124-31. doi: 10.1016/j.meatsci.2015.11.020. Epub 2015 Nov 24.

PMID:
26656871
8.

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial.

Allenbach Y, Guiguet M, Rigolet A, Marie I, Hachulla E, Drouot L, Jouen F, Jacquot S, Mariampillai K, Musset L, Grenier P, Devilliers H, Hij A, Boyer O, Herson S, Benveniste O.

PLoS One. 2015 Nov 5;10(11):e0133702. doi: 10.1371/journal.pone.0133702. eCollection 2015.

9.

Lymphopoiesis in transgenic mice over-expressing Artemis.

Rivera-Munoz P, Abramowski V, Jacquot S, André P, Charrier S, Lipson-Ruffert K, Fischer A, Galy A, Cavazzana M, de Villartay JP.

Gene Ther. 2016 Feb;23(2):176-86. doi: 10.1038/gt.2015.95. Epub 2015 Oct 1.

PMID:
26361272
10.

Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics.

de Angelis MH, Nicholson G, Selloum M, White J, Morgan H, Ramirez-Solis R, Sorg T, Wells S, Fuchs H, Fray M, Adams DJ, Adams NC, Adler T, Aguilar-Pimentel A, Ali-Hadji D, Amann G, André P, Atkins S, Auburtin A, Ayadi A, Becker J, Becker L, Bedu E, Bekeredjian R, Birling MC, Blake A, Bottomley J, Bowl M, Brault V, Busch DH, Bussell JN, Calzada-Wack J, Cater H, Champy MF, Charles P, Chevalier C, Chiani F, Codner GF, Combe R, Cox R, Dalloneau E, Dierich A, Di Fenza A, Doe B, Duchon A, Eickelberg O, Esapa CT, El Fertak L, Feigel T, Emelyanova I, Estabel J, Favor J, Flenniken A, Gambadoro A, Garrett L, Gates H, Gerdin AK, Gkoutos G, Greenaway S, Glasl L, Goetz P, Da Cruz IG, Götz A, Graw J, Guimond A, Hans W, Hicks G, Hölter SM, Höfler H, Hancock JM, Hoehndorf R, Hough T, Houghton R, Hurt A, Ivandic B, Jacobs H, Jacquot S, Jones N, Karp NA, Katus HA, Kitchen S, Klein-Rodewald T, Klingenspor M, Klopstock T, Lalanne V, Leblanc S, Lengger C, le Marchand E, Ludwig T, Lux A, McKerlie C, Maier H, Mandel JL, Marschall S, Mark M, Melvin DG, Meziane H, Micklich K, Mittelhauser C, Monassier L, Moulaert D, Muller S, Naton B, Neff F, Nolan PM, Nutter LM, Ollert M, Pavlovic G, Pellegata NS, Peter E, Petit-Demoulière B, Pickard A, Podrini C, Potter P, Pouilly L, Puk O, Richardson D, Rousseau S, Quintanilla-Fend L, Quwailid MM, Racz I, Rathkolb B, Riet F, Rossant J, Roux M, Rozman J, Ryder E, Salisbury J, Santos L, Schäble KH, Schiller E, Schrewe A, Schulz H, Steinkamp R, Simon M, Stewart M, Stöger C, Stöger T, Sun M, Sunter D, Teboul L, Tilly I, Tocchini-Valentini GP, Tost M, Treise I, Vasseur L, Velot E, Vogt-Weisenhorn D, Wagner C, Walling A, Weber B, Wendling O, Westerberg H, Willershäuser M, Wolf E, Wolter A, Wood J, Wurst W, Yildirim AÖ, Zeh R, Zimmer A, Zimprich A; EUMODIC Consortium, Holmes C, Steel KP, Herault Y, Gailus-Durner V, Mallon AM, Brown SD.

Nat Genet. 2015 Sep;47(9):969-978. doi: 10.1038/ng.3360. Epub 2015 Jul 27.

11.

Blastocyst genotyping for quality control of mouse mutant archives: an ethical and economical approach.

Scavizzi F, Ryder E, Newman S, Raspa M, Gleeson D, Wardle-Jones H, Montoliu L, Fernandez A, Dessain ML, Larrigaldie V, Khorshidi Z, Vuolteenaho R, Soininen R, André P, Jacquot S, Hong Y, de Angelis MH, Ramirez-Solis R, Doe B.

Transgenic Res. 2015 Oct;24(5):921-7. doi: 10.1007/s11248-015-9897-1. Epub 2015 Jul 16.

12.

Chromosomal instability but lack of transformation in human myoblast preparations.

Bisson A, Le Corre S, Joly-Helas G, Chambon P, Demoulins L, Jean L, Adriouch S, Drouot L, Giverne C, Roussel F, Jacquot S, Doucet C, Michot F, Lamacz M, Frébourg T, Flaman JM, Boyer O.

Cell Transplant. 2014;23(12):1475-87. doi: 10.3727/096368913X670192.

PMID:
25565635
13.

Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study.

Trouvin AP, Jacquot S, Grigioni S, Curis E, Dedreux I, Roucheux A, Boulard H, Vittecoq O, Le Loët X, Boyer O, Goëb V.

Clin Exp Immunol. 2015 Apr;180(1):11-8. doi: 10.1111/cei.12481.

14.

Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.

Colliou N, Picard D, Caillot F, Calbo S, Le Corre S, Lim A, Lemercier B, Le Mauff B, Maho-Vaillant M, Jacquot S, Bedane C, Bernard P, Caux F, Prost C, Delaporte E, Doutre MS, Dreno B, Franck N, Ingen-Housz-Oro S, Chosidow O, Pauwels C, Picard C, Roujeau JC, Sigal M, Tancrede-Bohin E, Templier I, Eming R, Hertl M, D'Incan M, Joly P, Musette P.

Sci Transl Med. 2013 Mar 6;5(175):175ra30. doi: 10.1126/scitranslmed.3005166.

15.

Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.

Hocqueloux L, Avettand-Fènoël V, Jacquot S, Prazuck T, Legac E, Mélard A, Niang M, Mille C, Le Moal G, Viard JP, Rouzioux C; AC32 (Coordinated Action on HIV Reservoirs) of the Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS).

J Antimicrob Chemother. 2013 May;68(5):1169-78. doi: 10.1093/jac/dks533. Epub 2013 Jan 20.

PMID:
23335199
16.

Highly-efficient, fluorescent, locus directed cre and FlpO deleter mice on a pure C57BL/6N genetic background.

Birling MC, Dierich A, Jacquot S, Hérault Y, Pavlovic G.

Genesis. 2012 Jun;50(6):482-9. doi: 10.1002/dvg.20826. Epub 2012 Mar 20.

PMID:
22121025
17.

Number and phenotype of rheumatoid arthritis patients' CD4+CD25hi regulatory T cells are not affected by adalimumab or etanercept.

Blache C, Lequerré T, Roucheux A, Beutheu S, Dedreux I, Jacquot S, Le Loët X, Boyer O, Vittecoq O.

Rheumatology (Oxford). 2011 Oct;50(10):1814-22. doi: 10.1093/rheumatology/ker183. Epub 2011 Jul 26.

PMID:
21791546
18.

Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response.

Picard D, Janela B, Descamps V, D'Incan M, Courville P, Jacquot S, Rogez S, Mardivirin L, Moins-Teisserenc H, Toubert A, Benichou J, Joly P, Musette P.

Sci Transl Med. 2010 Aug 25;2(46):46ra62. doi: 10.1126/scitranslmed.3001116.

19.

Indoor smoking ordinances in workplaces and public places in Kansas.

Neuberger JS, Davis K, Nazir N, Dunton N, Winn K, Jacquot S, Moler D.

Nicotine Tob Res. 2010 Aug;12(8):828-33. doi: 10.1093/ntr/ntq089. Epub 2010 Jun 9.

PMID:
20534777
20.

Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice.

Marty C, Lacout C, Martin A, Hasan S, Jacquot S, Birling MC, Vainchenker W, Villeval JL.

Blood. 2010 Aug 5;116(5):783-7. doi: 10.1182/blood-2009-12-257063. Epub 2010 May 14.

21.

B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease.

Mouillot G, Carmagnat M, Gérard L, Garnier JL, Fieschi C, Vince N, Karlin L, Viallard JF, Jaussaud R, Boileau J, Donadieu J, Gardembas M, Schleinitz N, Suarez F, Hachulla E, Delavigne K, Morisset M, Jacquot S, Just N, Galicier L, Charron D, Debré P, Oksenhendler E, Rabian C; DEFI Study Group.

J Clin Immunol. 2010 Sep;30(5):746-55. doi: 10.1007/s10875-010-9424-3. Epub 2010 May 1.

PMID:
20437084
22.

Reduced frequency of regulatory T cells in peripheral blood stem cell compared to bone marrow transplantations.

Blache C, Chauvin JM, Marie-Cardine A, Contentin N, Pommier P, Dedreux I, François S, Jacquot S, Bastit D, Boyer O.

Biol Blood Marrow Transplant. 2010 Mar;16(3):430-4. doi: 10.1016/j.bbmt.2009.10.027. Epub 2009 Oct 31.

23.

Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.

Lartigue A, Colliou N, Calbo S, François A, Jacquot S, Arnoult C, Tron F, Gilbert D, Musette P.

J Immunol. 2009 Nov 15;183(10):6207-16. doi: 10.4049/jimmunol.0803219. Epub 2009 Oct 19.

24.

B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses.

Mouquet H, Musette P, Gougeon ML, Jacquot S, Lemercier B, Lim A, Gilbert D, Dutot I, Roujeau JC, D'Incan M, Bedane C, Tron F, Joly P.

J Invest Dermatol. 2008 Dec;128(12):2859-69. doi: 10.1038/jid.2008.178. Epub 2008 Jun 19.

25.

Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study.

Mandillo S, Tucci V, Hölter SM, Meziane H, Banchaabouchi MA, Kallnik M, Lad HV, Nolan PM, Ouagazzal AM, Coghill EL, Gale K, Golini E, Jacquot S, Krezel W, Parker A, Riet F, Schneider I, Marazziti D, Auwerx J, Brown SD, Chambon P, Rosenthal N, Tocchini-Valentini G, Wurst W.

Physiol Genomics. 2008 Aug 15;34(3):243-55. doi: 10.1152/physiolgenomics.90207.2008. Epub 2008 May 27. Erratum in: Physiol Genomics. 2010 Feb,40(3):217.

26.

Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation.

Marie-Cardine A, Divay F, Dutot I, Green A, Perdrix A, Boyer O, Contentin N, Tilly H, Tron F, Vannier JP, Jacquot S.

Clin Immunol. 2008 Apr;127(1):14-25. doi: 10.1016/j.clim.2007.11.013. Epub 2008 Jan 10.

PMID:
18191619
27.

A single cycle of rituximab for the treatment of severe pemphigus.

Joly P, Mouquet H, Roujeau JC, D'Incan M, Gilbert D, Jacquot S, Gougeon ML, Bedane C, Muller R, Dreno B, Doutre MS, Delaporte E, Pauwels C, Franck N, Caux F, Picard C, Tancrede-Bohin E, Bernard P, Tron F, Hertl M, Musette P.

N Engl J Med. 2007 Aug 9;357(6):545-52.

28.

Duodenal intraepithelial T lymphocytes in patients with functional dyspepsia.

Gargala G, Lecleire S, François A, Jacquot S, Déchelotte P, Ballet JJ, Favennec L, Ducrotté P.

World J Gastroenterol. 2007 Apr 28;13(16):2333-8.

29.

Antidonor humoral transfer induces transplant arteriosclerosis in aortic and cardiac graft models in rats.

Alkhatib B, Freguin-Bouilland C, Litzler PY, Jacquot S, Lallemand F, Henry JP, Thuillez C, Plissonnier D.

J Thorac Cardiovasc Surg. 2007 Mar;133(3):791-7.

30.

[Heterogeneity and function of human B lymphocytes].

Jacquot S, Boyer O.

Med Sci (Paris). 2006 Dec;22(12):1075-80. Review. French.

31.

Deletion of the Coffin-Lowry syndrome gene Rsk2 in mice is associated with impaired spatial learning and reduced control of exploratory behavior.

Poirier R, Jacquot S, Vaillend C, Soutthiphong AA, Libbey M, Davis S, Laroche S, Hanauer A, Welzl H, Lipp HP, Wolfer DP.

Behav Genet. 2007 Jan;37(1):31-50. Epub 2006 Oct 11.

PMID:
17033934
32.

ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome.

Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G.

Cell. 2004 Apr 30;117(3):387-98.

33.

[B-cell anomalies in systemic lupus erythematosus].

Tron F, Jacquot S, Gilbert D.

Ann Med Interne (Paris). 2002 Dec;153(8):503-12. French.

PMID:
12610424
34.

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience.

Cutuli B, Cohen-Solal-le Nir C, de Lafontan B, Mignotte H, Fichet V, Fay R, Servent V, Giard S, Charra-Brunaud C, Lemanski C, Auvray H, Jacquot S, Charpentier JC.

Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):868-79.

PMID:
12095552
35.
36.

The ribosomal S6 kinases, cAMP-responsive element-binding, and STAT3 proteins are regulated by different leukemia inhibitory factor signaling pathways in mouse embryonic stem cells.

Boeuf H, Merienne K, Jacquot S, Duval D, Zeniou M, Hauss C, Reinhardt B, Huss-Garcia Y, Dierich A, Frank DA, Hanauer A, Kedinger C.

J Biol Chem. 2001 Dec 7;276(49):46204-11. Epub 2001 Oct 1.

37.

B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients.

Jacquot S, Maçon-Lemaître L, Paris E, Kobata T, Tanaka Y, Morimoto C, Schlossman SF, Tron F.

Int Immunol. 2001 Jul;13(7):871-6.

PMID:
11431417
38.

Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome.

Delaunoy J, Abidi F, Zeniou M, Jacquot S, Merienne K, Pannetier S, Schmitt M, Schwartz C, Hanauer A.

Hum Mutat. 2001 Feb;17(2):103-16.

PMID:
11180593
39.

Fusobacterium nucleatum hepatic abscess with pylephlebitis associated with idiopathic CD4(+) T lymphocytopenia.

Etienne M, Gueit I, Abboud P, Pons JL, Jacquot S, Caron F.

Clin Infect Dis. 2001 Jan 15;32(2):326-8. No abstract available.

PMID:
11170936
40.

CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses.

Morimoto S, Kanno Y, Tanaka Y, Tokano Y, Hashimoto H, Jacquot S, Morimoto C, Schlossman SF, Yagita H, Okumura K, Kobata T.

J Immunol. 2000 Apr 15;164(8):4097-104.

41.

Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.

Mérienne K, Jacquot S, Zeniou M, Pannetier S, Sassone-Corsi P, Hanauer A.

Oncogene. 2000 Aug 31;19(37):4221-9.

42.

CD27/CD70 interactions regulate T dependent B cell differentiation.

Jacquot S.

Immunol Res. 2000;21(1):23-30. Review.

PMID:
10803880
43.

Unreported RSK2 missense mutation in two male sibs with an unusually mild form of Coffin-Lowry syndrome.

Manouvrier-Hanu S, Amiel J, Jacquot S, Merienne K, Moerman A, Coëslier A, Labarriere F, Vallée L, Croquette MF, Hanauer A.

J Med Genet. 1999 Oct;36(10):775-8.

44.

Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3.

Sassone-Corsi P, Mizzen CA, Cheung P, Crosio C, Monaco L, Jacquot S, Hanauer A, Allis CD.

Science. 1999 Aug 6;285(5429):886-91.

45.

Coffin-Lowry syndrome: current status.

Jacquot S, Merienne K, Trivier E, Zeniou M, Pannetier S, Hanauer A.

Am J Med Genet. 1999 Jul 30;85(3):214-5. No abstract available.

PMID:
10398230
46.

Cardiac involvement in Coffin-Lowry syndrome.

Massin MM, Radermecker MA, Verloes A, Jacquot S, Grenade T.

Acta Paediatr. 1999 Apr;88(4):468-70.

PMID:
10342551
47.

A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation.

Merienne K, Jacquot S, Pannetier S, Zeniou M, Bankier A, Gecz J, Mandel JL, Mulley J, Sassone-Corsi P, Hanauer A.

Nat Genet. 1999 May;22(1):13-4. No abstract available.

PMID:
10319851
48.

Novel mutations in Rsk-2, the gene for Coffin-Lowry syndrome (CLS).

Abidi F, Jacquot S, Lassiter C, Trivier E, Hanauer A, Schwartz CE.

Eur J Hum Genet. 1999 Jan;7(1):20-6.

49.

Germline mosaicism in Coffin-Lowry syndrome.

Jacquot S, Merienne K, Pannetier S, Blumenfeld S, Schinzel A, Hanauer A.

Eur J Hum Genet. 1998 Nov-Dec;6(6):578-82.

50.

Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations.

Jacquot S, Merienne K, De Cesare D, Pannetier S, Mandel JL, Sassone-Corsi P, Hanauer A.

Am J Hum Genet. 1998 Dec;63(6):1631-40.

Supplemental Content

Loading ...
Support Center